期刊文献+

Pokemon、mdm2蛋白在乳腺癌中的表达及临床意义 被引量:10

Expression and clinical significance of Pokemon and mdm2 proteins in breast cancer
下载PDF
导出
摘要 目的探讨Pokemon和mdm2蛋白与乳腺癌发生、发展的关系及其临床意义。方法采用免疫组织化学S-P法检测54例乳腺癌及18例正常乳腺组织中Pokemon和mdm2蛋白的表达水平,分析其与乳腺癌临床病理学特征的关系,以及Pokemon与mdm2蛋白的相关性。结果在乳腺癌和正常乳腺组织中,Pokemon蛋白的阳性表达率分别为74.1%(40/54)、16.7%(3/18);mdm2蛋白的阳性表达率分别为81.5%(44/54)、22.2%(4/18)。两组中Pokemon与mdm2蛋白的阳性表达率均有统计学意义(P<0.05)。Pokemon和mdm2蛋白的表达与乳腺癌腋窝淋巴结转移相关(P<0.05),与年龄、肿瘤大小、TNM分期、生存期无关(P>0.05)。Pokemon蛋白表达与mdm2蛋白表达呈正相关(rs=0.588,P<0.05)。结论Pokemon与mdm2蛋白可能共同参与了乳腺癌的发生、发展和转移。Pokemon有望成为乳腺癌治疗的一个有效的靶基因,从而为乳腺癌基因治疗开辟新的途径。 Objective To discuss the clinical significance of POK erythroid myeloid ontogenic factor (Pokemon) and mdm2 expressions in breast cancer. Methods The Pokemon and mdm2 proteins in 54 breast tumor tissues and 18 normal breast tissues were detected by lmmunohistochemistry. The relationship between the expressions of Pokemon and mdm2 and clinic-pathological features of breast cancer were analyzed. Results In the tissues of breast cancer and normal breast, the positive expression rate of Pokemon protein was 74. 1% (40/54) and 16.7% (3/18), respectively; the corresponding data of mdm2 was 81.5 % (44/54) and 22.2% (4/18), respectively. To Pokemon and mdm2 expressions, there was a statistically significant difference between the group of breast cancer and normal case ( P 〈 0.05 ). In breast cancer tissue, the positive expression rates of Pokemon and mdm2 protein were correlated with metastasis of axillary lymph nodes (P 〈 0.05 ), but were not related with the age, the size of tumor, stage of TNM and life span ( P 〉 0.05 ). There was a positive correlation between the expressions of the Pokemon and mdm2 ( rs = 0.588 , P 〈 0.05 ). Conclusion The Pokemon and mdm2 proteins may involve in genesis, development and metastasis of breast cancer. The Pokemon may be a target gene of breast cancer therapy.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2008年第6期601-604,共4页 Journal of Harbin Medical University
基金 黑龙江省科技攻关计划资助项目(GB06C40108)
关键词 乳腺癌 POKEMON MDM2 免疫组织化学 breast cancer Pokemon mdm2 immunohistochemistry
  • 相关文献

参考文献9

  • 1张保宁.乳腺癌临床研究的回顾与展望[J].中华医学杂志,2005,85(1):7-8. 被引量:47
  • 2Maeda T, Hobbs RM, Merghoub T, et al. Role of the protooncogene Pokemon in cellular transformation and ARF repression [ J ]. Nature,2005,433 (7023) :278-285.
  • 3Maeda T, Robin M, Hobbs RM,et al. The transcription factor pokemon:a new keyplayer in cancer pathogenesis [ J ]. Cancer Res, 2005,65 (19) :8575-8578.
  • 4Morrison DJ, Pendergrast PS, Stavropoulos P, et al. FBI a factor thatbinds to the HIV-1 inducer of short transcripts (IST) ,is a poz domain protein [ J ]. Nucleic Acid Res, 1999,5 (27) : 1251-1262.
  • 5Lee DK, Suh D, Edenberg H J, et al. POZ Domain Transcription Factor , FBI-1, Represses Transcription of ADH5/ FDH by Interacting with the Zinc Finger and Interfering with DNA Binding Activity of Sp1 [ J]. J Biol Chem,2002,277(30) :26761-26768.
  • 6He X, Dave VP, Zhang Y,et al. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment [ J ]. Nature,2005,433 ( 7028 ) : 826-833.
  • 7Qiao D, Gaitonde SV, Qi WQ, et al . Deoxycholic acid suppresser p53 by stimulating proteasome-medialed p53 protein degradation [ J ]. Carcinogenesis,2001,22 ( 6 ) :957 -964.
  • 8Damia G, Filiberti L, Vikhanshaya F, et al. Cisplatinum and taxol induce different patterns of p53 phosphorylation [ J ]. Neoplasia, 2001,3 (1) :10-16.
  • 9Gibson SL,Dai CY,Lee HW,et al. Inhibition of colon tumor p rogression and angiogenesis by the Ink4a /Arf locus [ J ]. Cancer Res,2003,63 (4) :742-746.

二级参考文献9

  • 1上海市肿瘤研究所流行病学研究室.2000年上海市恶性肿瘤发病率[J].肿瘤,2003,23:532-532.
  • 2Early Breast Cancer Trialists' Collaborative Group. Ovarian ablation in early breast cancer: overview of randomized trials.Lancet, 1996,348 : 1189-1196.
  • 3Early Breast Cancer Tfialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal cytotoxic, or immune therapy. Lancet, 1992, 339(8785): 71-85.
  • 4Stewart HT, Forrest AP, Everington D, et al. Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast caner. Br J Cancer, 1996,74:297-299.
  • 5Uematsu M, Bornstein B, Recht A, et al. Long-term results of pastoperative radiation therapy following mastectomy with and without chemotherapy in stage Ⅰ-Ⅲ breast cancer. Int J Radiat Oncol Biol Phys, 1993, 25 : 765-770.
  • 6Patel RT, Webster DJT, Mansel RE, et al. Is immediate postmastectomy reconstruction safe in the longterm. Eur J Surg Oncol,1993, 19: 372-375.
  • 7李连弟,饶克勤,张思维,鲁凤珠,邹小农.中国12市县1993年~1997年肿瘤发病和死亡登记资料统计分析[J].中国肿瘤,2002,11(9):497-507. 被引量:193
  • 8李玲,王启俊,祝伟星,邢秀梅.北京城区主要肿瘤发病率时间趋势分析及预测[J].中国肿瘤,2002,11(10):576-578. 被引量:19
  • 9张保宁,张涛,胡伟国,宣立学,周纯武,李槐,蒋力明,孙耘田,杨红鹰.乳腺微小钙化灶的定位切除和病理活检[J].肿瘤防治研究,2004,31(1):44-45. 被引量:8

共引文献46

同被引文献79

引证文献10

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部